Search Results - "Spitschak, Alf"

Refine Results
  1. 1

    Unraveling a tumor type-specific regulatory core underlying E2F1-mediated epithelial-mesenchymal transition to predict receptor protein signatures by Khan, Faiz M., Marquardt, Stephan, Gupta, Shailendra K., Knoll, Susanne, Schmitz, Ulf, Spitschak, Alf, Engelmann, David, Vera, Julio, Wolkenhauer, Olaf, Pützer, Brigitte M.

    Published in Nature communications (04-08-2017)
    “…Cancer is a disease of subverted regulatory pathways. In this paper, we reconstruct the regulatory network around E2F, a family of transcription factors whose…”
    Get full text
    Journal Article
  2. 2

    MiR-205-5p and miR-342-3p cooperate in the repression of the E2F1 transcription factor in the context of anticancer chemotherapy resistance by Lai, Xin, Gupta, Shailendra K, Schmitz, Ulf, Marquardt, Stephan, Knoll, Susanne, Spitschak, Alf, Wolkenhauer, Olaf, Pützer, Brigitte M, Vera, Julio

    Published in Theranostics (2018)
    “…High rates of lethal outcome in tumour metastasis are associated with the acquisition of invasiveness and chemoresistance. Several clinical studies indicate…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Drug Repurposing at the Interface of Melanoma Immunotherapy and Autoimmune Disease by Spitschak, Alf, Gupta, Shailendra, Singh, Krishna P, Logotheti, Stella, Pützer, Brigitte M

    Published in Pharmaceutics (27-12-2022)
    “…Cancer cells have a remarkable ability to evade recognition and destruction by the immune system. At the same time, cancer has been associated with chronic…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Rewiring E2F1 with classical NHEJ via APLF suppression promotes bladder cancer invasiveness by Richter, Christin, Marquardt, Stephan, Li, Fanghua, Spitschak, Alf, Murr, Nico, Edelhäuser, Berdien A H, Iliakis, George, Pützer, Brigitte M, Logotheti, Stella

    “…Bladder cancer progression has been associated with dysfunctional repair of double-strand breaks (DSB), a deleterious type of DNA lesions that fuel genomic…”
    Get full text
    Journal Article
  7. 7

    Mechanisms of Functional Pleiotropy of p73 in Cancer and Beyond by Logotheti, Stella, Richter, Christin, Murr, Nico, Spitschak, Alf, Marquardt, Stephan, Pützer, Brigitte M.

    “…The transcription factor p73 is a structural and functional homolog of TP53, the most famous and frequently mutated tumor-suppressor gene. The TP73 gene can…”
    Get full text
    Journal Article
  8. 8

    Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis by Marquardt, Stephan, Solanki, Manish, Spitschak, Alf, Vera, Julio, Pützer, Brigitte M.

    Published in Seminars in cancer biology (01-12-2018)
    “…Metastasis is one of the most challenging issues in cancer patient management, and effective therapies to specifically target disease progression are missing,…”
    Get full text
    Journal Article
  9. 9

    Abstract 3092: Effect of cancer stem cell-specific progerin expression on metastatic potential by Morgenroth, Philipp, Söhnchen, Christoph, Spitschak, Alf, Puetzer, Brigitte M., Logotheti, Stella

    Published in Cancer research (Chicago, Ill.) (01-07-2021)
    “…Abstract Metastasis signals the final and treatment-refractory stage of cancer disease. Formation of metastases is fueled by a small cell subpopulation within…”
    Get full text
    Journal Article
  10. 10

    MiR-182 promotes cancer invasion by linking RET oncogene activated NF-κB to loss of the HES1/Notch1 regulatory circuit by Spitschak, Alf, Meier, Claudia, Kowtharapu, Bhavani, Engelmann, David, Pützer, Brigitte M

    Published in Molecular cancer (26-01-2017)
    “…Dominant-activating mutations in the RET proto-oncogene, a receptor tyrosine kinase, are responsible for the development of medullary thyroid carcinoma (MTC)…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Abstract 6814: E2F1-induced autocrine IL-6 inflammatory loop mediates cancer-immune cell crosstalk that regulates metastatic properties in melanoma by Dhar, Prabir, Singh, Krishna P., Gupta, Shailendra K., Peringot, Dhanya, Spitschak, Alf, Pützer, Brigitte M.

    Published in Cancer research (Chicago, Ill.) (22-03-2024)
    “…Abstract Melanoma is a cancer that is metastatic, drug-refractory and fatal if managed late or inadequately. The transcription factor E2F1 is a key player in…”
    Get full text
    Journal Article
  14. 14

    Adenoviral mediated expression of anti-inflammatory progranulin by placental explants modulates endothelial cell activation by decrease of ICAM-1 expression by Stubert, Johannes, Szewczyk, Marlen, Spitschak, Alf, Knoll, Susanne, Richter, Dagmar-Ulrike, Pützer, Brigitte M.

    Published in Placenta (Eastbourne) (15-01-2020)
    “…Functional disorders of the villous trophoblast may result in preeclampsia through the release of endothelial activating substances. Progranulin is an…”
    Get full text
    Journal Article
  15. 15

    Epigenetic factor EPC1 is a master regulator of DNA damage response by interacting with E2F1 to silence death and activate metastasis-related gene signatures by Wang, Yajie, Alla, Vijay, Goody, Deborah, Gupta, Shailendra K, Spitschak, Alf, Wolkenhauer, Olaf, Pützer, Brigitte M, Engelmann, David

    Published in Nucleic acids research (08-01-2016)
    “…Transcription factor E2F1 is a key regulator of cell proliferation and apoptosis. Recently, it has been shown that aberrant E2F1 expression often detectable in…”
    Get full text
    Journal Article
  16. 16

    DNp73-induced degradation of tyrosinase links depigmentation with EMT-driven melanoma progression by Fürst, Katharina, Steder, Marc, Logotheti, Stella, Angerilli, Alessandro, Spitschak, Alf, Marquardt, Stephan, Schumacher, Toni, Engelmann, David, Herchenröder, Ottmar, Rupp, Ralph A.W., Pützer, Brigitte M.

    Published in Cancer letters (01-02-2019)
    “…Melanoma is an aggressive cancer with poor prognosis, requiring personalized management of advanced stages and establishment of molecular markers. Melanomas…”
    Get full text
    Journal Article
  17. 17

    Integrated Loss of miR-1/miR-101/miR-204 Discriminates Metastatic from Nonmetastatic Penile Carcinomas and Can Predict Patient Outcome by Hartz, Juliane M, Engelmann, David, Fürst, Katharina, Marquardt, Stephan, Spitschak, Alf, Goody, Deborah, Protzel, Chris, Hakenberg, Oliver W, Pützer, Brigitte M

    Published in The Journal of urology (01-08-2016)
    “…Purpose Penile squamous cell carcinoma is a rare but aggressive cancer. Little is known about pivotal events in tumor pathogenesis and metastasis. Lymph node…”
    Get full text
    Journal Article
  18. 18

    Immune responses to WT1 in patients with AML or MDS after chemotherapy and allogeneic stem cell transplantation by Casalegno‐Garduño, Rosaely, Schmitt, Anita, Spitschak, Alf, Greiner, Jochen, Wang, Lei, Hilgendorf, Inken, Hirt, Carsten, Ho, Anthony D., Freund, Mathias, Schmitt, Michael

    Published in International journal of cancer (01-04-2016)
    “…Wilms' tumor gene 1 (WT1) is overexpressed in leukemia and WT1‐derived CD8+ T‐cell epitopes for immunotherapies targeting WT1 have been defined. Here, we…”
    Get full text
    Journal Article
  19. 19

    Association of RHAMM with E2F1 promotes tumour cell extravasation by transcriptional up-regulation of fibronectin by Meier, Claudia, Spitschak, Alf, Abshagen, Kerstin, Gupta, Shailendra, Mor, Joel M., Wolkenhauer, Olaf, Haier, Jörg, Vollmar, Brigitte, Alla, Vijay, Pützer, Brigitte M.

    Published in The Journal of pathology (01-11-2014)
    “…Dissemination of cancer cells from primary to distant sites is a complex process; little is known about the genesis of metastatic changes during disease…”
    Get full text
    Journal Article
  20. 20

    Abstract B26: Epigenetic master regulator EPC1 is a decisive factor for E2F1 to silence cell death and activate metastatic gene signatures in response to DNA damage by Engelmann, David, Wang, Yajie, Alla, Vijay, Goody, Deborah, Gupta, Shailendra K., Spitschak, Alf, Pützer, Brigitte M.

    Published in Cancer research (Chicago, Ill.) (01-04-2016)
    “…Abstract The transcription factor E2F1 is a key regulator of cell proliferation and apoptosis. Recently, it has been shown that aberrant E2F1 expression often…”
    Get full text
    Journal Article